Global Orthobiologics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Orthobiologics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Orthobiologics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Orthobiologics market is projected to reach US$ 7262.8 million in 2034, increasing from US$ 5289.6 million in 2022, with the CAGR of 4.6% during the period of 2024 to 2034. Demand from Hospitals and Ambulatory Surgical Centres are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Orthobiologics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Orthobiologics key manufacturers include Medtronic, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Orthofix International N.V., Anika Therapeutics, Inc., DePuy Synthes (Johnson & Johnson), Bioventus and Arthrex, Inc., etc. Medtronic, NuVasive, Inc., Stryker Corporation are top 3 players and held % sales share in total in 2022.
Orthobiologics can be divided into Bone Growth Stimulators (BGS), Viscosupplements and Bone Graft Substitute,, etc. Bone Growth Stimulators (BGS) is the mainstream product in the market, accounting for % sales share globally in 2022.
Orthobiologics is widely used in various fields, such as Hospitals, Ambulatory Surgical Centres and Orthopaedics Clinics,, etc. Hospitals provides greatest supports to the Orthobiologics industry development. In 2022, global % sales of Orthobiologics went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orthobiologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Medtronic
NuVasive, Inc.
Stryker Corporation
Zimmer Biomet Holdings
Orthofix International N.V.
Anika Therapeutics, Inc.
DePuy Synthes (Johnson & Johnson)
Bioventus
Arthrex, Inc.
SeaSpine Holdings Corporation
Sanofi-Aventis (Sanofi SA)
Djo Global, Inc.
Seikagaku Corporation
RTI Surgical, Inc.
Heraeus Holding GmbH
Fidia Pharma USA Inc.
TRB Chemedica International SA
Allosource
Musculoskeletal Transplant Foundation, Inc.
Ito
Segment by Type
Bone Growth Stimulators (BGS)
Viscosupplements
Bone Graft Substitute
Hospitals
Ambulatory Surgical Centres
Orthopaedics Clinics
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Orthobiologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Orthobiologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Orthobiologics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Orthobiologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Orthobiologics introduction, etc. Orthobiologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Orthobiologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Orthobiologics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Orthobiologics key manufacturers include Medtronic, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Orthofix International N.V., Anika Therapeutics, Inc., DePuy Synthes (Johnson & Johnson), Bioventus and Arthrex, Inc., etc. Medtronic, NuVasive, Inc., Stryker Corporation are top 3 players and held % sales share in total in 2022.
Orthobiologics can be divided into Bone Growth Stimulators (BGS), Viscosupplements and Bone Graft Substitute,, etc. Bone Growth Stimulators (BGS) is the mainstream product in the market, accounting for % sales share globally in 2022.
Orthobiologics is widely used in various fields, such as Hospitals, Ambulatory Surgical Centres and Orthopaedics Clinics,, etc. Hospitals provides greatest supports to the Orthobiologics industry development. In 2022, global % sales of Orthobiologics went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Orthobiologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Medtronic
NuVasive, Inc.
Stryker Corporation
Zimmer Biomet Holdings
Orthofix International N.V.
Anika Therapeutics, Inc.
DePuy Synthes (Johnson & Johnson)
Bioventus
Arthrex, Inc.
SeaSpine Holdings Corporation
Sanofi-Aventis (Sanofi SA)
Djo Global, Inc.
Seikagaku Corporation
RTI Surgical, Inc.
Heraeus Holding GmbH
Fidia Pharma USA Inc.
TRB Chemedica International SA
Allosource
Musculoskeletal Transplant Foundation, Inc.
Ito
Segment by Type
Bone Growth Stimulators (BGS)
Viscosupplements
Bone Graft Substitute
Segment by Application
Hospitals
Ambulatory Surgical Centres
Orthopaedics Clinics
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Orthobiologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Orthobiologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Orthobiologics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Orthobiologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Orthobiologics introduction, etc. Orthobiologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Orthobiologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
